You are here

Medtech investor Clearbridge Health plans Catalist IPO

It expects operating expenses to go up in the near term after IPO, and can't be certain that it will achieve profitability

Singapore

CLEARBRIDGE Health, the medtech investor formerly known as Clearbridge Accelerator, is planning an initial public offering (IPO) on the Singapore Exchange.

Clearbridge Health, which was renamed in April, lodged a draft prospectus for a listing on the Catalist board last

sentifi.com

Market voices on:

Powered by GET.comGetCom